Skip to Main Content (Press Enter)

Logo UNIBS
  • ×
  • Home
  • Persone
  • Strutture
  • Competenze
  • Pubblicazioni
  • Professioni
  • Corsi
  • Insegnamenti
  • Terza Missione

Competenze & Professionalità
Logo UNIBS

|

Competenze & Professionalità

unibs.it
  • ×
  • Home
  • Persone
  • Strutture
  • Competenze
  • Pubblicazioni
  • Professioni
  • Corsi
  • Insegnamenti
  • Terza Missione
  1. Pubblicazioni

Dietary Geraniol by Oral or Enema Administration Strongly Reduces Dysbiosis and Systemic Inflammation in Dextran Sulfate Sodium-Treated Mice

Articolo
Data di Pubblicazione:
2016
Abstract:
Trans)-3,7-Dimethyl-2,6-octadien-1-ol, commonly called geraniol (Ge-OH), is an acyclic monoterpene alcohol with well-known anti-inflammatory, antitumoral, and antimicrobial properties. It is widely used as a preservative in the food industry and as an antimicrobial agent in animal farming. The present study investigated the role of Ge-OH as an anti-inflammatory and anti-dysbiotic agent in the dextran sulfate sodium (DSS)-induced colitis mouse model. Ge-OH was orally administered to C57BL/6 mice at daily doses of 30 and 120 mg kg(−1) body weight, starting 6 days before DSS treatment and ending the day after DSS removal. Furthermore, Ge-OH 120 mg kg(−1) dose body weight was administered via enema during the acute phase of colitis to facilitate its on-site action. The results show that orally or enema-administered Ge-OH is a powerful antimicrobial agent able to prevent colitis-associated dysbiosis and decrease the inflammatory systemic profile of colitic mice. As a whole, Ge-OH strongly improved the clinical signs of colitis and significantly reduced cyclooxygenase-2 (COX-2) expression in colonocytes and in the gut wall. Ge-OH could be a powerful drug for the treatment of intestinal inflammation and dysbiosis
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
geraniol; Dextran sulfate sodium; Inflammatory bowel disease; Cyclooxygenase-2; , Colorectal cancer.
Elenco autori:
De Fazio, L; Spisni, E; Cavazza, E; Strillacci, A; Candela, M; Centanni, M; Ricci, C; Rizzello, F; Campieri, M; Valerii, Mc
Autori di Ateneo:
RICCI CHIARA
Link alla scheda completa:
https://iris.unibs.it/handle/11379/558116
Link al Full Text:
https://iris.unibs.it/retrieve/handle/11379/558116/157490/De%20Fazio%20Front%20Pharmacol.pdf
Pubblicato in:
FRONTIERS IN PHARMACOLOGY
Journal
  • Assistenza
  • Privacy
  • Utilizzo dei cookie
  • Note legali

Realizzato con VIVO | Designed by Cineca | 26.5.1.0